DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Cyamemazine
Cyamemazine
Information for the Patient Losartan Potassium/Hydrochlorothiazide 100
The Effects of Antipsychotic Treatment on Metabolic Function: a Systematic Review and Network Meta-Analysis
Antipsychotics
Drugs with Anticholinergic Properties, Cognitive Decline, and Dementia in an Elderly General Population: the 3-City Study
Screening of 300 Drugs in Blood Utilizing Second Generation
Emea/666243/2009
Clozapine/Cyamemazine 985 Verse Effects, Clozapine Therapy Should Be Introduced Account
(12) United States Patent (10) Patent No.: US 6,720,318 B2 Dib Et Al
The Anticholinergic Impregnation Scale: Towards The
Drug Interactions with Proton Pump Inhibitor Or Infectious Etiologies? Sophie Wagner, M
PROPULSID® (Cisapride) Limited Access Program
Binding of Levomepromazine and Cyamemazine to Human Recombinant Dopamine Receptor Subtypes
Electronic Search Strategies
Haloperidol Decreases the Turnover of GABA in the Striatum, Whereas Clozapine Increases the Turnover of GABA in the Substantia Nigra
Use of Very-High-Dose Olanzapine in Treatment-Resistant Schizophrenia Jean-Marie Batail, B
Drug/Substance Trade Name(S)
(2006.01) A61P 25/36 (2006.01) A61K 9/00 (2006.01) (21) International Application Number: PCT/US20 19/059852 (22) International Filing Date: 05 November 2019 (05
Comparative Analysis of Anti-Toxoplasmic Activity of Antipsychotic Drugs and Valproate Running Title : Anti-Toxoplasmic Activity of Antipsychotics and Valproate
Top View
An Improved Process for the Preparation of Pure Cyamemazine and Salts Thereof
Pharmacotherapy of Patients Taking New Psychoactive Substances: a Systematic Review and Analysis of Case Reports
Product List
Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
Antipsychotics and Torsadogenic Risk: Signals Emerging from the US FDA Adverse Event Reporting System Database
Development and Validation of Rp-Hplc Method for The
Study Protocol
False-Positive Drug Test Results in Patients Taking Psychotropic Drugs
Of 10 Package Leaflet: Information for the User Olmetec Plus 40 Mg/12.5
The Serotonin-7 Receptor As a Novel Therapeutic Target
Clozapine and Obsessive-Compulsive Symptoms Across Major Psycho=C Disorders - a Review of Three Cases
Core Safety Profile
Alterations in Brain Neurotrophic Factor Expression Levels Esen Gümüşlü1 , Oğuz Mutlu2
PROPULSID® (Cisapride)
Unusual Cause of ST Elevation Georges Elhomsy, M.D
Psychopharmacological Treatment of Depression Psychopharmacological Treatment of Depression
Mhra Public Assessment Report
Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017
Antipsychotics for Treatment of Delirium in Hospitalised Non-ICU Patients
Photoallergic Reaction to Cyamemazine [Escholarship]
Supplementary Material
Université De Nantes
Drug Challenge in Brugada Syndrome: How Valuable Is It?
Summary of Product Characteristics, Labelling
Preclinical and Clinical Pharmacology of Cyamemazine: Anxiolytic Effects and Prevention of Alcohol and Benzodiazepine Withdrawal Syndrome
Psychotropic Drugs and Skin: an Association